A Pink Sheet article reports that China has passed a sweeping new national Biosecurity Law, which will have a far-reaching impact on the life sciences industry in the country.
Life sciences regulatory & compliance partner Katherine Wang (Shanghai) explains that, under the new law, fines will increase significantly in cases where overseas organizations are alleged to have collected, preserved or exported Chinese human genetic resources. Katherine anticipates an increase in enforcement activity, and she encourages multinational life sciences companies to carefully review their ongoing research and commercial initiatives.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.